Myomo, Inc. logo

MYO Earnings Date: Nov 9, 2026 (Estimated) — Myomo, Inc.

AMEX · Healthcare · Medical Devices

Updated

Price $1.24
Market Cap $49.1M
P/E -3.6
52W Range $0.60 – $1.89
Next Earnings · After close (est.)

When is MYO's next earnings date?

Myomo, Inc. (MYO) is expected to report Q3 2026 earnings on Monday, November 9, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.08 on revenue of $11.5M.

How did MYO do in its last earnings report?

In its most recent report on Aug 5, 2026 (Q2 2026), Myomo, Inc. posted EPS of -$0.09 versus the -$0.10 estimate, a beat of 10.0%. Revenue was $11.7M against a $10.4M estimate. The stock's 1-day post-earnings move was +23.6%.

How much does MYO stock move after earnings?

MYO beat EPS estimates in 6 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 20.7% (up or down) in the day after earnings.

About Myomo, Inc.

Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Health Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-05Q2 2026-0.10-0.09+10.00%$11.7M✅ Beat+23.58%+43.40%+32.08%
2026-05-07Q1 2026-0.12-0.07+41.67%$10.1M✅ Beat-5.05%+1.88%+46.86%
2026-03-09Q4 2025-0.09-0.09+0.00%$11.4M➖ Inline-16.80%-8.81%-16.18%
2025-11-10Q3 2025-0.11-0.09+18.18%$10.1M✅ Beat-7.31%-16.03%+16.68%
2025-08-11Q2 2025-0.11-0.11+0.00%$9.7M➖ Inline-38.64%-36.36%-50.44%
2025-03-10Q4 2024-0.02-0.01+50.00%$12.1M✅ Beat+40.77%+30.46%+6.47%
2024-11-06Q3 2024-0.04-0.03+25.00%$9.2M✅ Beat+20.10%+12.92%+44.02%
2024-08-06Q2 2024-0.09-0.03+66.67%$7.5M✅ Beat-13.33%-8.81%-10.24%

Showing last 8 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .